Entering text into the input field will update the search result below

Lexicon Pharma reports Q2 results

  • Lexicon Pharmaceuticals (NASDAQ:LXRX -6.5%) Q2 results: Revenues: $0.4M (-42.9%); R&D Expense: $20.8M (-1.9%); SG&A: $6.3M (+21.2%); Operating Loss: ($26.7M) (-2.3%); Net Loss: ($28.1M) (-8.1%); Loss Per Share: ($0.27) (+22.9%); Quick Assets: $282.5M (-16.7%).
  • No guidance given.

Recommended For You

More Trending News

About LXRX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
LXRX--
Lexicon Pharmaceuticals, Inc.